Literature DB >> 11374468

Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket.

K Schwach-Abdellaoui1, A Monti, J Barr, J Heller, R Gurny.   

Abstract

Local delivery of antimicrobial agents in inflamed periodontal pocket has been shown to be effective in reducing periodontopathic microorganisms. This research focuses on developing and characterizing bioerodible formulations based on auto-catalyzed poly(ortho esters) (POExLAy) for modulated release of tetracycline over 2 weeks. POExLAy are a new versatile family of POE-containing lactoyl lactyl dimers in the polymer backbone. By modifying the proportion of lactic acid in the polymer, viscous or solid materials having different degradation rate can be produced. The formulations can be either injected or placed as a solid device directly into the periodontal pocket. Tetracycline-free base incorporated into these materials was released within 10-14 days depending on polymer structure. Increase in lactic acid content in the polymer tended to increase the drug release rate and to reduce the initial lag time. Tetracycline release from such bioerodible delivery system occurs predominantly by surface erosion of the polymeric matrix, leading to kinetics which can be zero order. This periodontal drug delivery system is designed to be used as an adjunct in the treatment of periodontal diseases. Clinical studies are currently in progress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11374468     DOI: 10.1016/s0142-9612(00)00327-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

1.  A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases.

Authors:  H Hau; R Rohanizadeh; M Ghadiri; W Chrzanowski
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

2.  Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: preliminary trial in humans.

Authors:  K Schwach-Abdellaoui; P J Loup; N Vivien-Castioni; A Mombelli; P Baehni; J Barr; J Heller; R Gurny
Journal:  AAPS PharmSci       Date:  2002

3.  Multiple applications of flurbiprofen and chlorhexidine chips in patients with chronic periodontitis: a randomized, double blind, parallel, 2-arms clinical trial.

Authors:  Eli E Machtei; Ilan Hirsh; Maher Falah; Eyal Shoshani; Avi Avramoff; Adel Penhasi
Journal:  J Clin Periodontol       Date:  2011-09-15       Impact factor: 8.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.